Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1807 studies found for:    "Hepatitis C"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Hepatitis C Testing in VA Community-Based Outpatient Clinics
Condition: Hepatitis C
Intervention: Other: QI
2 Completed Australian Trial in Acute Hepatitis C
Condition: Hepatitis C
Interventions: Drug: Pegylated Interferon alfa 2a;   Drug: Ribavirin (HIV conifected patients only)
3 Completed Undiagnosed Hepatitis C Infection in an Urban Hospital
Condition: Hepatitis C
Intervention: Other: Observation only, no intervention
4 Completed Pegaferon and Ribavirin for Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Pegaferon (pegylated interferon alpha 2a) + ribavirin
5 Completed
Has Results
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Condition: Hepatitis C
Interventions: Drug: BMS-790052 (NS5A Replication Complex Inhibitor);   Drug: Placebo matching BMS-790052;   Drug: Pegylated-interferon alfa 2a;   Drug: Ribavirin
6 Completed Fluvastatin Versus Hepatitis C Virus
Condition: Hepatitis C
Intervention: Drug: fluvastatin
7 Completed
Has Results
Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients
Condition: Hepatitis C
Intervention: Drug: Alisporivir
8 Completed Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects
Condition: Hepatitis C
Interventions: Drug: EDP239;   Drug: Placebo
9 Completed A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients
Condition: Hepatitis C
Interventions: Drug: BMS-790052 (Daclatasvir);   Drug: BMS-650032 (Asunaprevir)
10 Completed
Has Results
Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: MP-424 (Telaprevir)
11 Completed
Has Results
Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation
Condition: Hepatitis C
Interventions: Drug: Cyclosporine;   Drug: Tacrolimus
12 Not yet recruiting The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital
Condition: Hepatitis C
Intervention: Other: community based hepatitis C care and treatment
13 Recruiting An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection
Condition: Hepatitis C Virus
Intervention:
14 Completed A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Condition: Hepatitis C
Interventions: Drug: GSK2336805 10mg;   Drug: GSK2336805 30mg;   Drug: GSK2236805 100mg;   Drug: GSK2236805 200mg;   Drug: GSK2236805 10mg;   Drug: GSK2236805 dose to be determined up to 100mg;   Drug: GSK2236805 5mg;   Drug: GSK2236805 30mg
15 Terminated
Has Results
Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Condition: Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: telaprevir
16 Active, not recruiting Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Condition: Hepatitis C
Interventions: Drug: Simeprivir (SMV);   Drug: Sofosbuvir (SOF);   Drug: Ribavirin (RBV)
17 Completed
Has Results
A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)
Condition: Hepatitis C
Intervention: Drug: TMC435
18 Withdrawn Rosuvastatin for Hepatitis C
Condition: Hepatitis C
Intervention: Drug: rosuvastatin
19 Recruiting Prevalence and Screening of Hepatitis C in Belgium in 2015
Condition: Hepatitis C
Interventions: Other: Questionnaire;   Procedure: HCV serology
20 Completed Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Silymarin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.